Title : Doxorubicin enhances TRAIL-induced apoptosis in prostate cancer.

Pub. Date : 2002 May

PMID : 11956588






7 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Doxorubicin enhances TRAIL-induced apoptosis in prostate cancer. Doxorubicin TNF superfamily member 10 Homo sapiens
2 The anthracycline doxorubicin (DOX) can sensitize several types of cancer cells to TRAIL-mediated apoptosis. Doxorubicin TNF superfamily member 10 Homo sapiens
3 The anthracycline doxorubicin (DOX) can sensitize several types of cancer cells to TRAIL-mediated apoptosis. Doxorubicin TNF superfamily member 10 Homo sapiens
4 Here we report that DOX enhances TRAIL-induced apoptosis and cytotoxicity against prostate cancer cells. Doxorubicin TNF superfamily member 10 Homo sapiens
5 These findings indicate that DOX enhances TRAIL-induced apoptosis and cytotoxicity in prostate cancer by activation of caspase cascades, and suggest that TRAIL in combination with DOX have a therapeutic potential in the treatment of prostate cancer. Doxorubicin TNF superfamily member 10 Homo sapiens
6 These findings indicate that DOX enhances TRAIL-induced apoptosis and cytotoxicity in prostate cancer by activation of caspase cascades, and suggest that TRAIL in combination with DOX have a therapeutic potential in the treatment of prostate cancer. Doxorubicin TNF superfamily member 10 Homo sapiens
7 These findings indicate that DOX enhances TRAIL-induced apoptosis and cytotoxicity in prostate cancer by activation of caspase cascades, and suggest that TRAIL in combination with DOX have a therapeutic potential in the treatment of prostate cancer. Doxorubicin TNF superfamily member 10 Homo sapiens